This inventor holds 2 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Alexion Pharmaceuticals, Inc., Lonza Inc.. Active years: 2000-2016.
Company Filing History:
Years Active: 2000-2016
Title: Innovations and Contributions of Inventor Andreas Brunner
Introduction
Andreas Brunner is a notable inventor based in Brig, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the synthesis of compounds that address medical deficiencies. With a total of 2 patents, his work has implications for treating diseases associated with molybdenum cofactor deficiency.
Latest Patents
Brunner's latest patents include innovative methods for synthesizing molybdopterin precursor Z derivatives. These synthetic methods provide a means to prepare compounds that are crucial for treating specific medical conditions. Additionally, he has developed a process for preparing cyclobutane-1,2-dicarboxylic esters, which are intermediates in the synthesis of pharmaceutically active compounds. This process involves the use of maleic or fumaric esters and ketene acetals in the presence of a Lewis acid and a sterically hindered base, showcasing his expertise in organic chemistry.
Career Highlights
Throughout his career, Brunner has worked with prominent companies in the pharmaceutical industry, including Alexion Pharmaceuticals and Lonza. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in drug development.
Collaborations
Brunner has collaborated with talented individuals such as Xiangtian Long and Danmei Dai. These partnerships have likely enhanced his research and innovation efforts, leading to impactful results in his field.
Conclusion
Andreas Brunner's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.